Published in Rev Infect Dis on February 19, 1981
Effects of pH on the activity of ketoconazole against Candida albicans. Antimicrob Agents Chemother (1983) 3.06
Polyoxin D inhibits growth of zoopathogenic fungi. Antimicrob Agents Chemother (1983) 1.89
Collaborative evaluation in seven laboratories of a standardized micromethod for yeast susceptibility testing. J Clin Microbiol (1988) 1.71
Toxic hepatis during ketoconazole treatment. Br Med J (Clin Res Ed) (1981) 1.23
Comparison of ketoconazole, Bay N7133, and Bay L9139 in the treatment of experimental vaginal candidiasis. Antimicrob Agents Chemother (1983) 1.18
Therapeutic potential of the inhibition of the retinoic acid hydroxylases CYP26A1 and CYP26B1 by xenobiotics. Curr Top Med Chem (2013) 0.82
Susceptibility of zygomycetes to amphotericin B, miconazole, and ketoconazole. Antimicrob Agents Chemother (1981) 0.78
Dermatology-important advances in clinical medicine: ketoconazole. West J Med (1983) 0.75
Enilconazole as an adjunct to the treatment of four cases of canine nasal aspergillosis. Can Vet J (1991) 0.75
Ketoconazole, an oral antifungal: laboratory and clinical assessment of imidazole drugs. Postgrad Med J (1979) 3.55
Reasons for loss to follow-up among mothers registered in a prevention-of-mother-to-child transmission program in rural Malawi. Trans R Soc Trop Med Hyg (2008) 2.50
Levamisole in the modulation of the immune response: the current experimental and clinical state. J Reticuloendothel Soc (1977) 2.15
Phylogenetic relationships within the cyst-forming nematodes (Nematoda, Heteroderidae) based on analysis of sequences from the ITS regions of ribosomal DNA. Mol Phylogenet Evol (2001) 1.50
Adjunctive steroid treatment in acute bacterial meningitis. "To do or not to do: that is the question". Acta Clin Belg (2011) 1.44
Restoration of host defense mechanisms in man by levamisole. Life Sci (1973) 1.38
The mitochondrial genome of Xiphinema americanum sensu stricto (Nematoda: Enoplea): considerable economization in the length and structural features of encoded genes. J Mol Evol (2005) 1.38
Letter: Treatment of recurrent aphthous stomatitis and herpes with levamisole. Br Med J (1974) 1.36
Acute blood-pressure-lowering effect of ketanserin. Lancet (1981) 1.29
Site of action of low dose ketoconazole on androgen biosynthesis in men. J Clin Endocrinol Metab (1983) 1.27
[Therapy of systemic candidiasis using miconazol]. Med Welt (1974) 1.22
Evaluation of T cell subsets with monoclonal antibodies in patients with rheumatoid arthritis. J Rheumatol (1982) 1.19
Effect of food and gastric acidity on absorption of orally administered ketoconazole. Clin Pharm (1988) 1.16
Cinnarizine in peripheral vascular insufficiency. Studies on blood flow, muscle capacity, and vascular tone. Arzneimittelforschung (1971) 1.13
Haemorheological effects of ketanserin, a selective 5-HT2 receptor antagonist, in aged, spontaneously hypertensive dogs. Arch Int Pharmacodyn Ther (1982) 1.13
Levamisole in rheumatoid arthritis--a multivariate analysis of a multicentric study. J Rheumatol Suppl (1978) 1.11
Letter: Impaired neutrophil phagocytosis. Lancet (1974) 1.10
The treatment of aspergillosis and aspergilloma with itraconazole, clinical results of an open international study (1982-1987). Mycoses (1988) 1.09
The arteriolar effects of cinnarizine and flunarizine. Multitechnical investigations in normal volunteers and in patients with occlusive disease of the extremities secondary to arteriosclerosis. Angiology (1974) 1.04
The acute antihypertensive effect of ketanserin increases with age. J Cardiovasc Pharmacol (1985) 1.02
Loperamide (R 18 553), a novel type of antidiarrheal agent. Part 7: Clinical investigation. Efficacy and safety of loperamide in patients with severe chronic diarrhea. Arzneimittelforschung (1974) 1.00
Prevention and cure of aggressiveness in pigs using the sedative azaperone. Vet Rec (1969) 1.00
Letter: Chemotherapy of candidiasis. Br Med J (1974) 0.97
Accelerated HIV testing for PMTCT in maternity and labour wards is vital to capture mothers at a critical point in the programme at district level in Malawi. AIDS Care (2010) 0.94
Adverse reactions to levamisole. Cancer Treat Rep (1978) 0.94
The role of Pityrosporum pachydermatis in otitis externa of dogs: evaluation of a treatment with miconazole. Vet Rec (1979) 0.91
A clinical trial design avoiding undue placebo treatment. J Clin Pharmacol (1975) 0.90
Loperamide (R 18 553), a novel type of antidiarrheal agent. Part 6: Clinical pharmacology. Placebo-controlled comparison of the constipating activity and safety of loperamide, diphenoxylate and codeine in normal volunteers. Arzneimittelforschung (1974) 0.90
Ketanserin and QTc prolongation. Eur Heart J (1987) 0.89
Itraconazole in the treatment of human mycoses: review of three years of clinical experience. Rev Infect Dis (1987) 0.88
An international double-blind clinical evaluation of pimozide. J Clin Pharmacol New Drugs (1972) 0.88
[Microbial contamination of drugs -- ecology and antibiotic resistance (author's transl)]. J Pharm Belg (1980) 0.87
Selection of a highly virulent fungal isolate, Metarhizium anisopliae CLO 53, for controlling Hoplia philanthus. J Invertebr Pathol (2004) 0.86
Marked increase of Pseudomonas aeruginosa serotype 012 in Belgium since 1982. Eur J Clin Microbiol Infect Dis (1988) 0.85
Levamisole and agranulocytosis. Lancet (1977) 0.85
Antihypertensive properties of ketanserin (R 41 468). Fed Proc (1983) 0.84
A multi-center, double-blind comparison of ketoconazole and griseofulvin in the treatment of infections due to dermatophytes. Rev Infect Dis (1981) 0.84
Bone Dysplasia as a Key Feature in Three Patients with a Novel Congenital Disorder of Glycosylation (CDG) Type II Due to a Deep Intronic Splice Mutation in TMEM165. JIMD Rep (2012) 0.83
Ketanserin compared to nifedipine and methyldopa in patients aged above 50 years: two international multicentre studies. For the International Study Group. J Hypertens Suppl (1986) 0.83
Loperamide (R 18 553), a novel type of antidiarrheal agent. Part 8: Clinical investigation. Use of a flexible dosage schedule in a double-blind comparison of loperamide with diphenoxylate in 614 patients suffering from acute diarrhea. Arzneimittelforschung (1974) 0.82
Studies on the sensitivity and specificity of the Limulus amebocyte lysate test and rabbit pyrogen assays. Appl Environ Microbiol (1985) 0.82
Plethysmographic registration of volume changes in a hand vein. Effects of serotonin and of a specific antagonist. Angiology (1980) 0.81
Bactericidal activity of disinfectants on Listeria. J Appl Bacteriol (1993) 0.81
Ketanserin in acute superficial thrombophlebitis. Lancet (1982) 0.80
Benzetimide in the treatment of diarrhoea in newborn calves and adult cattle. Vet Rec (1974) 0.80
The radioactive microsphere method for the assessment of regional myocardial blood flow after coronary artery occlusion. Inaccuracies due to variations in the diameter distribution of the spheres. Pflugers Arch (1975) 0.80
Evolution of class A G-protein-coupled receptors: implications for molecular modeling. Curr Med Chem (2012) 0.78
Prolactin, phenothiazines, admission to mental hospital, and carcinoma of the breast. Lancet (1973) 0.77
Phage typing of coagulase-negative staphylococci. J Clin Pharm Ther (1992) 0.77
Administration of nebivolol after coronary artery bypass in patients with altered left ventricular function. J Cardiovasc Pharmacol (1993) 0.76
'Difficult asthma': can symptoms be controlled in a structured environment? Pediatr Pulmonol (2009) 0.76
Safety of alternative medicines reconsidered: lead-induced anaemia caused by an indian ayurvedic formulation. Acta Clin Belg (2008) 0.76
The host and the parasite. Postgrad Med J (1979) 0.75
Changed cervical kinematics after fusion surgery. Eur Spine J (2011) 0.75
Clinical response to therapy with thymopoietin pentapeptide (TP-5) in rheumatoid arthritis. Ann Rheum Dis (1982) 0.75
[Immunopharmacology of levamisole]. Z Hautkr (1979) 0.75
[Clinical profile of a new antihypertensive agents. Ketanserin]. Rev Med Liege (1988) 0.75
[Cause of error in reading antibiograms: presence of an unlabelled antiseptic on the disks]. Acta Clin Belg (1976) 0.75
Ketanserin in the treatment of peripheral vascular disease or hypertension in patients with diabetes mellitus: a review. J Cardiovasc Pharmacol (1991) 0.75
Resting, exercise and postexercise heart rate and systolic time intervals in normal men treated with lidoflazine. Arzneimittelforschung (1973) 0.75
[Hypothesis for the use of levamisole in rheumatic diseases (author's transl)]. MMW Munch Med Wochenschr (1977) 0.75
Novocaine and Curarisation. Proc Natl Acad Sci U S A (1923) 0.75
Cisapride in the treatment of chronic intestinal pseudo-obstruction. Z Gastroenterol (1990) 0.75
Treatment of systemic mycoses with miconazole: a review. Mod Med Asia (1977) 0.75
[Comments on Staphylococcus aureus investigations in medicines (author's transl)]. J Pharm Belg (1979) 0.75
[Contribution to the immunochemical analysis of organ extracts: beef liver and horse liver]. J Pharm Belg (1969) 0.75
Degree of responsiveness to levamisole and factors influencing responsiveness and adverse reactions. J Rheumatol Suppl (1978) 0.75
[Microbial purity of vegetal drugs and their mixtures (author's transl)]. J Pharm Belg (1980) 0.75
[Preparation, hydrolysis and resorption of chloramphenicol palmitate-suspensions]. Pharmazie (1966) 0.75
[Endotoxins and their biological effects (author's transl)]. J Pharm Belg (1979) 0.75
Successful treatment of chronic esophageal candidosis with oral ketoconazole. Mykosen (1982) 0.75
Modulation of immunity in multiple sclerosis: a double-blind levamisole-placebo controlled study in 85 patients. J Neurol (1982) 0.75
[Clopirac in traumatology (author's transl)]. J Belge Rhumatol Med Phys (1975) 0.75
Ketoconazole, a new step in the management of fungal disease. Prog Drug Res (1983) 0.75
Vascular Protection by Ketanserin, a 5-HT(2) Serotonergic Receptor Antagonist? Platelets (1991) 0.75
Levamisole in ascariasis. A multicenter controlled evaluation. Am J Trop Med Hyg (1978) 0.75
Double-blind comparison of ketanserin with placebo in patients with essential hypertension. Angiology (1986) 0.75
[Some considerations on the microbiological titration of antibiotics described in the European Pharmacopoeia (author's transl)]. J Pharm Belg (1976) 0.75
[Where do surgical possibilities stop in the treatment of pulmonary tuberculosis?]. Clinique (Paris) (1965) 0.75
[Microbiology of drugs]. Bull Mem Acad R Med Belg (1976) 0.75
[Study of the photochemical degradation of macrolides induced by riboflavine (author's transl)]. J Pharm Belg (1977) 0.75
Difenoxine (R 15403), the active metabolite of diphenoxylate (R 1132). 5. Clinical comparison of difenoxine and diphenoxylate in volunteers and in patients with chronic diarrhea. Double-blind cross-over assessments. Arzneimittelforschung (1972) 0.75
The use and limitations of a stratified randomization in surgical adjuvant studies of cancer. Eur J Cancer (1979) 0.75
[Biological adjustment of pharmaceutical preparations. Hemoadjustment]. J Pharm Belg (1972) 0.75
[Study of the possibilities of the use of immunochemical methods in the control of liver preparations in therapeutic use]. J Pharm Belg (1969) 0.75
[Determination of DL 50 on chick embryos as an analytic criterion in the control of drug quality]. J Pharm Belg (1969) 0.75
Background to the EULAR study. J Rheumatol Suppl (1978) 0.75
[Disinfectant evaluation. Preliminary laboratory in vitro tests (author's transl)]. J Pharm Belg (1978) 0.75
[Commentaires on the sterility test of the European Pharmacopoeia (author's transl)]. J Pharm Belg (1976) 0.75
Multinational evaluation of etomidate for anesthesia induction. Conclusions and consequences. Anaesthesist (1978) 0.75
[Reflections on the measurement of the germicidal action of antiseptic or disinfectant substances]. J Pharm Belg (1974) 0.75
[Microbiologic problems posed by cosmetics]. J Pharm Belg (1976) 0.75
[Electrophoretic and immunoelectrophoretic studies of injectable enzyme preparations: pancreatic and testicular preparations]. Prog Immunobiol Stand (1970) 0.75